Skip to content

effect of Agnimanta upanah means to tie the agnimantha churna mixed with oil in one group of patients and in another group glycerine magnesium sulphate dressing is applied in the management of cellulitis and there effect will be compared.

A randomised comparative clinical trial to evaluate the efficacy of agnimantha upanah with glycerine magnesium sulphate dressing in vranashopha

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021450
Enrollment
60
Registered
2019-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Agnimantha Upanah: Agnimantha (Premna mucronata) fine powder mixed with til tail will be heated and tied around the part which is inflamed and kept for 3-4 Hours and then it removed for

Sponsors

Ayurved Rugnalaya and multispeciality hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having the textual signs and symptoms of Aamavastha and pachamanavastha of Vranashotha The patients with vranshotha irrespective of sex and its dosha will be selected for the study all nija as well as Aagantuja Vranashotha

Exclusion criteria

Exclusion criteria: Vranshotha with Pakwavastha Patient with HIV, HCV, HBV infections, liver diseases Unncontrolled DM Inflammation with fracture Septicemia, severe anemia, bleeding disorder Intra-abdominal inflammatory condition

Design outcomes

Primary

MeasureTime frame
examine and Compare the effect of agnimantha upanah and glycerin mangnessium sulphate in vranshophaTimepoint: examine and Compare the effect of agnimantha upanah and glycerin mangnessium sulphate in vranshopha on each day of application for five days

Secondary

MeasureTime frame
Check if any adverse effectTimepoint: 5 days

Countries

India

Contacts

Public ContactDr Payal BAbasaheb Benkar

PDEAs C.A.R.C. NIGADI

dr.madhavibanarase209@gmail.com9423207569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026